I agree that this site is using cookies. You can find further informations here.
X
Allerton, Charlotte M. N.
~ 0  results:
Search for persons X
?
1

A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor..:

Allerton, Charlotte M. N. ; Arcari, Joel T. ; Aschenbrenner, Lisa M....
Journal of Medicinal Chemistry.  , 2024
Link: https://doi.org/10.1021/..
 
?
2

Designing small molecules for therapeutic success: A contem..:

Maurer, Tristan S. ; Edwards, Martin ; Hepworth, David..
Drug Discovery Today.  27 (2022)  2 - p. 538-546 , 2022
Link: https://doi.org/10.1016/..
 
?
3

An oral SARS-CoV-2 Mproinhibitor clinical candidate for the..:

Owen, Dafydd R. ; Allerton, Charlotte M. N. ; Anderson, Annaliesa S....
Science.  374 (2021)  6575 - p. 1586-1593 , 2021
Link: https://doi.org/10.1126/..
 
?
4

Design and synthesis of pyridazinone-based 5-HT2C agonists:

Allerton, Charlotte M.N. ; Andrews, Mark D. ; Blagg, Julian...
Bioorganic & Medicinal Chemistry Letters.  19 (2009)  19 - p. 5791-5795 , 2009
Link: https://doi.org/10.1016/..
 
?
5

Design and synthesis of piperazinylpyrimidinones as novel s..:

Andrews, Mark D. ; Green, Martin P. ; Allerton, Charlotte M.N....
Bioorganic & Medicinal Chemistry Letters.  19 (2009)  18 - p. 5346-5350 , 2009
Link: https://doi.org/10.1016/..
 
?
6

Design and synthesis of a functionally selective D3 agonist..:

Blagg, Julian ; Allerton, Charlotte M.N. ; Batchelor, David V.J....
Bioorganic & Medicinal Chemistry Letters.  17 (2007)  24 - p. 6691-6696 , 2007
Link: https://doi.org/10.1016/..
 
?
7

A Novel Series of Potent and Selective PDE5 Inhibitors with..:

Allerton, Charlotte M. N. ; Barber, Christopher G. ; Beaumont, Kevin C....
Journal of Medicinal Chemistry.  49 (2006)  12 - p. 3581-3594 , 2006
Link: https://doi.org/10.1021/..
 
?
8

Design, synthesis and biological activity of β-carboline-ba..:

Maw, Graham N. ; Allerton, Charlotte M.N. ; Gbekor, Eugene.
Bioorganic & Medicinal Chemistry Letters.  13 (2003)  8 - p. 1425-1428 , 2003
Link: https://doi.org/10.1016/..
 
?
9

Preclinical characterization of an intravenous coronavirus ..:

Boras, Britton ; Jones, Rhys M ; Anson, Brandon J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523698/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Discovery of a Novel Inhibitor of Coronavirus 3CL Protease ..:

Boras, Britton ; Jones, Rhys M ; Anson, Brandon J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491518/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

Prevalence of physical frailty, including risk factors, up ..:

Hamish J.C. McAuley ; Rachael A. Evans ; Charlotte E. Bolton...
http://www.sciencedirect.com/science/article/pii/S2589537023000731.  , 2023
Link: https://doi.org/10.1016/..
 
?
12

Preclinical characterization of an intravenous coronavirus ..:

Britton Boras ; Rhys M. Jones ; Brandon J. Anson...
https://doi.org/10.1038/s41467-021-26239-2.  , 2021
Link: https://doi.org/10.1038/..
 
?
13

UK healthcare professionals' attitudes towards the introduc..:

Sherman, Susan M. ; Allerton-Price, Charlotte ; Lingley-Heath, Nicola..
Vaccine.  42 (2024)  10 - p. 2621-2627 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Author Correction: Results of the phase IIa RADICAL trial o..:

Coombes, R. C. ; Badman, P. D. ; Lozano-Kuehne, J. P....
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
15

Results of the phase IIa RADICAL trial of the FGFR inhibito..:

Coombes, R. C. ; Badman, P. D. ; Lozano-Kuehne, J. P....
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
1-15